Friend turned foe: E-cadherin perversely protects micrometastases.
作者信息
Wells Alan, Ma Bo
机构信息
Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA.
出版信息
Transl Androl Urol. 2017 Apr;6(2):338-340. doi: 10.21037/tau.2017.03.25.
Abstract
摘要
相似文献
1
Friend turned foe: E-cadherin perversely protects micrometastases.友变敌：E-钙黏蛋白反常地保护微转移灶。
Transl Androl Urol. 2017 Apr;6(2):338-340. doi: 10.21037/tau.2017.03.25.
2
Friend or foe: role of E-cadherin in prostate cancer metastasis.敌友之间：E-钙黏蛋白在前列腺癌转移中的作用
Transl Androl Urol. 2016 Dec;5(6):961-963. doi: 10.21037/tau.2016.11.08.
3
[Microbial "friend-foe" identification in human intestine microsymbiocenosis].[人体肠道微共生群落中微生物“敌友”识别]
Zh Mikrobiol Epidemiol Immunobiol. 2011 Nov-Dec(6):46-51.
4
High density lipoproteins and kidney function: the friend turned foe?高密度脂蛋白与肾功能：朋友会变成敌人吗？
J Thorac Dis. 2016 Nov;8(11):2978-2981. doi: 10.21037/jtd.2016.11.66.
5
Intrahepatic micrometastases around liver metastases from gastric cancer.胃癌肝转移灶周围的肝内微转移
J Hepatobiliary Pancreat Surg. 2009;16(4):493-501. doi: 10.1007/s00534-009-0081-y. Epub 2009 Apr 10.
6
FRIEND or FOE: A prospective evaluation of risk factors for reintubation in surgical and trauma patients.友敌：手术和创伤患者再次插管的风险因素的前瞻性评估。
Am J Surg. 2018 Dec;216(6):1056-1062. doi: 10.1016/j.amjsurg.2018.07.004. Epub 2018 Jul 10.
7
Extracellular hemoglobin: the case of a friend turned foe.细胞外血红蛋白：从朋友到敌人的转变
Front Physiol. 2015 Apr 20;6:96. doi: 10.3389/fphys.2015.00096. eCollection 2015.
8
[Hypothesis of "immunological testing" of partners--systems of "friend and foe" recognition in historical prospect].[伴侣“免疫检测”假说——历史视角下的“敌我”识别系统]
Izv Akad Nauk Ser Biol. 2006 Jul-Aug(4):389-403.
9
The physician-patient privilege: friend or foe?医生-患者特权：是友还是敌？
Physician Exec. 1995 Feb;21(2):16-8.
10
Liver protects metastatic prostate cancer from induced death by activating E-cadherin signaling.肝脏通过激活E-钙黏蛋白信号通路保护转移性前列腺癌免于诱导性死亡。
Hepatology. 2016 Nov;64(5):1725-1742. doi: 10.1002/hep.28755. Epub 2016 Sep 23.
引用本文的文献
1
Deciphering the molecular mechanism of enhanced tumor activity of the EGFR variant T790M/L858R using melanoma cell lines.利用黑色素瘤细胞系解析表皮生长因子受体（EGFR）变体T790M/L858R增强肿瘤活性的分子机制。
Front Oncol. 2023 Jun 2;13:1163504. doi: 10.3389/fonc.2023.1163504. eCollection 2023.
本文引用的文献
1
Liver protects metastatic prostate cancer from induced death by activating E-cadherin signaling.肝脏通过激活E-钙黏蛋白信号通路保护转移性前列腺癌免于诱导性死亡。
Hepatology. 2016 Nov;64(5):1725-1742. doi: 10.1002/hep.28755. Epub 2016 Sep 23.
2
Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity.上皮与间充质状态之间的可塑性使上皮-间质转化与增强转移的干细胞能力脱钩。
Cell Rep. 2016 Mar 15;14(10):2281-8. doi: 10.1016/j.celrep.2016.02.034. Epub 2016 Mar 3.
3
Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance.肝细胞诱导乳腺癌和前列腺癌细胞中 E-钙黏蛋白的再表达增加了化疗耐药性。
Clin Exp Metastasis. 2012 Jan;29(1):39-50. doi: 10.1007/s10585-011-9427-3. Epub 2011 Oct 2.
4
Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases.乳腺癌和前列腺癌转移灶中的部分间充质向上皮逆向转变
Cancer Microenviron. 2012 Apr;5(1):19-28. doi: 10.1007/s12307-011-0085-4. Epub 2011 Sep 3.
5
Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.前列腺癌细胞转移的进展和 zeb1 及 SRC 家族激酶对上皮钙黏蛋白的调控。
Am J Pathol. 2011 Jul;179(1):400-10. doi: 10.1016/j.ajpath.2011.03.028. Epub 2011 May 4.
6
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program.雄激素非依赖性前列腺癌是一组异质性疾病：快速尸检项目的经验教训。
Cancer Res. 2004 Dec 15;64(24):9209-16. doi: 10.1158/0008-5472.CAN-04-2442.
7
Androgen receptor in prostate cancer.前列腺癌中的雄激素受体。
Endocr Rev. 2004 Apr;25(2):276-308. doi: 10.1210/er.2002-0032.
Zotero 插件